Liver Fibrosis Blood Test - Essential (FIB-4 Liver Check)

The Liver Fibrosis Blood Test - Essential (FIB-4 Liver Check) is a non-invasive screening tool designed to estimate the degree of liver fibrosis (scarring) using a combination of routine blood markers. It is particularly valuable for individuals with risk factors for liver disease, such as fatty liver, viral hepatitis, alcohol-related liver damage, or metabolic syndrome, who may not yet have symptoms. The FIB-4 index is a validated calculation derived from three simple blood tests: aspartate aminotransferase (AST), alanine transaminase (ALT), and platelet count. This test provides a risk score that helps clinicians decide whether further investigation, such as transient elastography or referral to a hepatologist, is warranted.

The test screens for:

Liver Enzymes
- Aspartate aminotransferase (AST / SGOT): An enzyme found in the liver and other tissues; elevated levels can indicate liver cell damage.
- Alanine transaminase (ALT / SGPT): A more liver-specific enzyme; elevated levels suggest active liver injury.

Platelet Count
- Platelets (PLT): A low platelet count can be a sign of advanced liver fibrosis or cirrhosis, as the liver plays a role in regulating platelet production and sequestration.

The FIB-4 index is calculated using a formula that incorporates these markers along with the patient's age. It is a simple, cost-effective method to assess liver fibrosis risk without the need for imaging or biopsy. The test requires only a standard blood sample, which is collected by a trained phlebotomist.

Why it matters
Liver changes often develop silently over time. The FIB-4 calculation offers a quick, non-invasive score to help identify individuals who may benefit from further clinical evaluation by their doctor. By combining routine blood markers, it helps stratify risk and guide timely clinical decisions, potentially avoiding more invasive procedures. Regular monitoring can also track disease progression or response to treatment, making it a valuable tool in both primary and specialist care.